Agios Pharmaceuticals, Inc. (AGIO) stock
AGIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/308% above fair value
$29.68−0.21 (-0.70%)
Close on Nov 18, 2026Market cap $1.77BP/E –Yield –
Agios Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Agios Pharmaceuticals's market cap was $1.96B on Nov 11, 2026, against $1.70B a year earlier. Over the last 5 years it ranged from $1.07B to $3.39B, with a median of $1.70B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.96B | +23.3% |
| 2025 | Dec 31, 2025 | $1.59B | -15.3% |
| 2024 | Dec 31, 2024 | $1.87B | +50.6% |
| 2023 | Dec 29, 2023 | $1.24B | -19.3% |
| 2022 | Dec 30, 2022 | $1.54B | -14.3% |
| 2021 | Dec 31, 2021 | $1.80B | -40.0% |
| 2020 | Dec 31, 2020 | $3.00B | +6.6% |
| 2019 | Dec 31, 2019 | $2.81B | +4.8% |
| 2018 | Dec 31, 2018 | $2.68B | -3.5% |
| 2017 | Dec 29, 2017 | $2.78B | +58.5% |
| 2016 | Dec 30, 2016 | $1.75B | -28.2% |
| 2015 | Dec 31, 2015 | $2.44B | -37.1% |
| 2014 | Dec 31, 2014 | $3.88B | +421.5% |
| 2013 | Dec 31, 2013 | $744.23M | – |
See a number that looks wrong?